Palo Alto Investors »

Proqr Thrapeutics N V shs euro shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2025-09-30 $402k 189k 2.13

More positions owned by Palo Alto Investors

Insmed (INSM)
Ptc Therapeutics I (PTCT)
ACADIA Pharmaceuticals (ACAD)
Amicus Therapeutics (FOLD)
BioMarin Pharmaceutical (BMRN)
Biogen Sponsored Ads (BIIB)
United Therapeutics Corporation (UTHR)
Anaptysbio Inc Common (ANAB)
Iovance Biotherapeutics Com New (IOVA)
Novocure Ltd ord (NVCR)
Dyne Therapeutics Sponsored Ads (DYN)
Disc Medicine (IRON)
Alnylam Pharmaceuticals (ALNY)
Gossamer Bio (GOSS)
Prothena Corp Com Cl A (PRTA)

View all positions for Palo Alto Investors

Top funds holding Proqr Thrapeutics N V shs euro

Adage Capital Partners GP
Privium Fund Management B.V.
Affinity Asset Advisors
Morgan Stanley
Standard Life Aberdeen
Sio Capital Management
Kynam Capital Management
DAFNA Capital Management
Siren
Arrowpoint Asset Management
Platinum Investment Mangement
M28 Capital Management
Ikarian Capital
Point72 Asset Management
Citadel Advisors

View all funds holding Proqr Thrapeutics N V shs euro